11:08 AM EST, 12/31/2024 (MT Newswires) -- Haleon ( HLN ) said Tuesday it has completed its acquisition of an additional 33% stake in its Chinese joint venture, Tianjin TSKF Pharmaceutical, from its partners Tianjin Pharmaceutical Group and Tianjin Pharmaceutical Da Ren Tang Group.

The total consideration was about 4.47 billion Chinese renminbi ($611.8 million), according to its regulatory filing. It expects the deal to be accretive to EPS.

Price: 9.58, Change: +0.07, Percent Change: +0.74